Medical management of patients with brain tumors

Current Treatment Options in Neurology

Volumn 13, Issue 4, 2011, Pages 413-426

  Pruitt, Amy A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BEVACIZUMAB; CALCIUM; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; DONEPEZIL; ETIRACETAM; GABAPENTIN; HARKOSERIDE; HEPARIN; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; METHYLPHENIDATE; METOCLOPRAMIDE; MIRTAZAPINE; MODAFINIL; ONDANSETRON; PHENOBARBITAL; PHENYTOIN; PROCHLORPERAZINE; TIAGABINE; VALPROIC ACID; VITAMIN D;

ACUTE DISEASE; ADVERSE OUTCOME; ANASTOMOSIS; ARTICLE; BLOOD CLOT LYSIS; BRAIN CANCER; BRAIN EDEMA; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CHRONIC DISEASE; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FATIGUE; GLUCOSE TOLERANCE; HUMAN; LEUKOENCEPHALOPATHY; LIFESTYLE MODIFICATION; LOADING DRUG DOSE; MEASLES LIKE RASH; MENTAL DISEASE; MOOD DISORDER; MYOPATHY; NAUSEA; PEPTIC ULCER; PNEUMOCYSTIS PNEUMONIA; PSYCHOSIS; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME;

EID: 80051669125     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-011-0132-y     Document Type: Article

References (50)

1. S Catt A Chalmers L Fallowfield 2008 Psychosocial and supportive-care needs in high-grade glioma Lancet Oncol 9 9 884 91 18760244 10.1016/S1470- 2045(08)70230-4
2. NS Wenger PM Vespa 2010 Ethical issues in patient-physician communication about therapy for cancer: professional responsibilities of the oncologist Oncologist 15 Suppl 1 43 8 20237217 10.1634/theoncologist.2010-S1-43
3. JF Wilson 2009 Cancer care: a microcosm of the problems facing all of health care Ann Intern Med 150 8 573 6 19380865
4. NL Keating MB Landrum SO Rogers Jr, et al. 2010 Physician factors associated with discussions about end-of-life care Cancer 116 4 998 1006 20066693 10.1002/cncr.24761
5. A Pace G Metro A Fabi 2010 Supportive care in neurooncology Curr Opin Oncol 22 6 621 6 20706120 10.1097/CCO.0b013e32833e078c This paper presents a sensitive, comprehensive look at the needs of this vulnerable population.
6. TT Batchelor TN Byrne 2006 Supportive care of brain tumor patients Hematol Oncol Clin North Am 20 6 1337 61 17113467 10.1016/j.hoc.2006.09.013 (Pubitemid 44755418)
7. CJ Watling JG Cairncross 2002 Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three cases J Neurosurg 97 1 224 6 12134920 10.3171/jns.2002.97.1.0224 1:CAS:528:DC%2BD38XlvVKnsrs%3D (Pubitemid 34693726)
8. CJ Vecht A Hovestadt HBC Verbiest, et al. 1994 Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day Neurology 44 675 80 8164824 1:STN:280:DyaK2c3hslyqtA%3D%3D (Pubitemid 24129996)
9. G Meyer K Badenhoop 2003 Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy Med Klin (Munich) 98 5 266 70 10.1007/s00063-003-1255-z (Pubitemid 36578218)
10. GL Nielsen HT Sorensen L Mellemkjoer, et al. 2001 Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study Am J Med 111 7 541 5 11705430 10.1016/S0002-9343(01)00941-X 1:CAS:528:DC%2BD3MXot1Omu74%3D (Pubitemid 33052352)
11. AK Mahindra SA Grossman 2003 Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors J Neurooncol 63 3 263 70 12892232 10.1023/A:1024217527650 (Pubitemid 36874010)
12. JA Kovacs VJ Gill S Meshnick, et al. 2001 New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia JAMA 286 19 2450 60 11712941 10.1001/jama.286.19.2450 1:CAS:528:DC%2BD3MXosF2ltrc%3D (Pubitemid 33098164)
13. MS Cooper PM Stewart 2003 Corticosteroid insufficiency in acutely ill patients N Engl J Med 348 8 727 34 12594318 10.1056/NEJMra020529 1:CAS:528:DC%2BD3sXhtlWjtb0%3D (Pubitemid 36237043)
14. DB Coursin KE Wood 2002 Corticosteroid supplementation for adrenal insufficiency JAMA 287 2 236 40 11779267 10.1001/jama.287.2.236 1:CAS:528:DC%2BD38XisVSmtw%3D%3D (Pubitemid 34251950)
15. GJ Wood JW Shega B Lynch, et al. 2007 Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time... nothing was working" JAMA 298 10 1196 207 17848654 10.1001/jama.298.10.1196 1:CAS:528:DC%2BD2sXhtVGmtL3L (Pubitemid 47403106)
16. JW Lee EB Bromfield S Kesari 2008 Antiemetic properties of the antiepileptic drug levetiracetam N Engl J Med 359 17 1853 18946077 10.1056/NEJMc0806761 1:CAS:528:DC%2BD1cXht12msrnE
17. MJ Glantz BF Cole PA Forsyth, et al. 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 54 10 1886 93 10822423 1:STN:280:DC%2BD3c3osVWhsA%3D%3D (Pubitemid 30327107)
18. MS van Breemen RM Rijsman MJ Taphoorn, et al. 2009 Efficacy of anti-epileptic drugs in patients with gliomas and seizures J Neurol 256 9 1519 26 19434440 10.1007/s00415-009-5156-9
19. HJ Mamon PY Wen AC Burns, et al. 1999 Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy Epilepsia 40 3 341 4 10080516 10.1111/j.1528-1157.1999.tb00715.x 1:STN:280:DyaK1M7nvVKjsw%3D%3D (Pubitemid 29164800)
20. RH Mattson 2004 Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use Rev Neurol Dis 1 Suppl 1 S10 7 16400290
21. TA Milligan S Hurwitz EB Bromfield 2008 Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery Neurology 71 9 665 9 18725591 10.1212/01.wnl.0000324624.52935.46 1:CAS:528:DC%2BD1cXpvFygtbw%3D This is the first study to show the utility of levetiracetam in brain tumor patients.
22. A Pace A Vidiri E Galie, et al. 2003 Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Ann Oncol 14 12 1722 6 14630675 10.1093/annonc/mdg502 1:STN:280: DC%2BD3srltVWgsw%3D%3D (Pubitemid 38029042)
23. A Fugh-Berman 2000 Herb-drug interactions Lancet 355 9198 134 8 10675182 10.1016/S0140-6736(99)06457-0 1:CAS:528:DC%2BD3cXptleluw%3D%3D (Pubitemid 30068565)
24. WA Weiger M Smith H Boon, et al. 2002 Advising patients who seek complementary and alternative medical therapies for cancer Ann Intern Med 137 11 889 903 12458989 (Pubitemid 35416625)
25. PY Wen D Schiff S Kesari, et al. 2006 Medical management of patients with brain tumors J Neurooncol 80 3 313 32 16807780 10.1007/s11060-006-9193-2 1:CAS:528:DC%2BD2sXptlGksQ%3D%3D (Pubitemid 44782910)
26. DC Walsh AK Kakkar 2001 Thromboembolism in brain tumors Curr Opin Pulm Med 7 5 326 31 11584184 10.1097/00063198-200109000-00013 1:STN:280: DC%2BD3MrjsFWhsA%3D%3D (Pubitemid 32929690)
27. LC Marras WH Geerts JR Perry 2000 The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review Cancer 89 3 640 6 10931464 10.1002/1097-0142(20000801)89:3<640::AID- CNCR20>3.0.CO;2-E 1:STN:280:DC%2BD3cvgt1aqsg%3D%3D (Pubitemid 30640111)
28. M Zangari LM Fink F Elice, et al. 2009 Thrombotic events in patients with cancer receiving antiangiogenesis agents J Clin Oncol 27 29 4865 73 19704059 10.1200/JCO.2009.22.3875 1:CAS:528:DC%2BD1MXhtlKjtLvK
29. JR Perry 2010 Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents Curr Opin Neurol 23 6 592 6 20881488 10.1097/WCO.0b013e32833feb73 1:CAS:528:DC%2BC3cXhtl2ltL%2FO
30. J Drappatz ET Wong D Schiff, et al. 2009 A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme Int J Radiat Oncol Biol Phys 73 1 222 7 18513880 10.1016/j.ijrobp. 2008.03.046 1:CAS:528:DC%2BD1cXhsFajsrfM
31. EO Jenkins D Schiff N Mackman, et al. 2010 Venous thromboembolism in malignant gliomas J Thromb Haemost 8 2 221 7 19912518 10.1111/j.1538-7836.2009. 03690.x 1:CAS:528:DC%2BC3cXisFKgs7w%3D This is an excellent summary of mechanisms of thrombosis in brain tumor patients.
32. PL Nghiemphu RM Green WB Pope, et al. 2008 Safety of anticoagulation use and bevacizumab in patients with glioma Neuro-Oncology 10 3 355 60 18436627 10.1215/15228517-2008-009
33. MB Streiff 2009 Diagnosis and initial treatment of venous thromboembolism in patients with cancer J Clin Oncol 27 29 4889 94 19738109 10.1200/JCO.2009.23.5788
34. GH Lyman AA Khorana A Falanga, et al. 2007 American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 34 5490 505 17968019 10.1200/JCO.2007.14.1283 1:CAS:528:DC%2BD1cXnvVChtA%3D%3D (Pubitemid 350232226)
35. MA Knovich GJ Lesser 2004 The management of thromboembolic disease in patients with central nervous system malignancies Curr Treat Options Oncol 5 6 511 7 15509484 10.1007/s11864-004-0039-x (Pubitemid 39591810)
36. MR Cesarone G Belcaro AN Nicolaides, et al. 2002 Venous thrombosis from air travel: the LONFLIT3 study-prevention with aspirin vs. low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial Angiology 53 1 1 6 10.1177/000331970205300101 (Pubitemid 34141884)
37. JR Perry JA Julian NJ Laperriere, et al. 2010 PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma J Thromb Haemost 8 9 1959 65 20598077 10.1111/j.1538-7836.2010.03973.x 1:CAS:528:DC%2BC3cXht1yrtr7M This study looked at primary prophylaxis of VTE in brain tumor patients with dalteparin versus placebo. There was a trend toward increased CNS bleeding in the dalteparin group, who also had reduced incidence of VTE.
38. AT Chan A Atiemo LK Diran, et al. 1999 Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis J Thromb Thrombolysis 8 2 139 42 10436144 10.1023/A:1008915202859 1:STN:280:DyaK1MzmsFCqsA%3D%3D (Pubitemid 29410839)
39. KL Triebel RC Martin LB Nabors, et al. 2009 Medical decision-making capacity in patients with malignant glioma Neurology 73 24 2086 92 20018637 10.1212/WNL.0b013e3181c67bce
40. JT Hickok JA Roscoe GR Morrow, et al. 2005 Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer Cancer 104 8 1772 8 16116608 10.1002/cncr.21364 (Pubitemid 41437444)
41. G Pelletier MJ Verhoef N Khatri, et al. 2002 Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues J Neurooncol 57 1 41 9 12125966 10.1023/A:1015728825642 (Pubitemid 34692613)
42. CA Meyers MA Weitzner AD Valentine, et al. 1998 Methylphenidate therapy improves cognition, mood, and function of brain tumor patients J Clin Oncol 16 7 2522 7 9667273 1:CAS:528:DyaK1cXks1Gnuro%3D (Pubitemid 28309050)
43. P Jean-Pierre GR Morrow JA Roscoe, et al. 2010 A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study Cancer 116 14 3513 20 20564068 10.1002/cncr.25083 1:CAS:528: DC%2BC3cXpvFWgtbs%3D
44. EG Shaw R Rosdhal RB D'Agostino Jr, et al. 2006 Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life J Clin Oncol 24 9 1415 20 16549835 10.1200/JCO.2005.03.3001 1:CAS:528:DC%2BD28Xjs1Ogt7s%3D (Pubitemid 46622007)
45. A Pruitt J Dalmau J Detre, et al. 2006 Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation Neurology 67 4 676 8 16707725 10.1212/01.wnl.0000228862.76269.62 1:STN:280:DC%2BD28vpvF2kug%3D%3D (Pubitemid 44273617)
46. SA Grimm J Yahalom LE Abrey, et al. 2006 Retinopathy in survivors of primary central nervous system lymphoma Neurology 67 11 2060 2 17159122 10.1212/01.wnl.0000247679.87738.1e (Pubitemid 44967393)
47. KC Oeffinger AC Mertens CA Sklar, et al. 2006 Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 15 1572 82 17035650 10.1056/NEJMsa060185 1:CAS:528:DC%2BD28XhtVyht7jL (Pubitemid 44547808)
48. O Al-Mefty C Topsakal S Pravdenkova, et al. 2004 Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics J Neurosurg 100 6 1002 13 15200115 10.3171/jns.2004.100.6.1002 (Pubitemid 38661613)
49. A El-Jawahri LM Podgurski AF Eichler, et al. 2010 Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial J Clin Oncol 28 2 305 10 19949010 10.1200/JCO.2009.24.7502 There was a robust shift toward preference for palliative care when patients viewed a video of options compared with verbal discussion alone.
50. ECA Kaal CJ Vecht 2004 The management of brain edema in brain tumors Curr Opin Oncol 16 593 600 15627023 10.1097/01.cco.0000142076.52721.b3 1:CAS:528:DC%2BD2cXhtVOqt7bI (Pubitemid 39482980)